Test-retest variability of high resolution positron emission tomography (PET) imaging of cortical serotonin (5HT2A) receptors in older, healthy adults

Tiffany W. Chow, David C. Mamo, Hiroyuki Uchida, Ariel Graff-Guerrero, Sylvain Houle, Gwenn Smith, Bruce G. Pollock, Benoit H. Mulsant

Research output: Contribution to journalArticle

Abstract

Background: Position emission tomography (PET) imaging using [18F]-setoperone to quantify cortical 5-HT2A receptors has the potential to inform pharmacological treatments for geriatric depression and dementia. Prior reports indicate a significant normal aging effect on serotonin 5HT2A receptor (5HT2AR) binding potential. The purpose of this study was to assess the test-retest variability of [18F]-setoperone PET with a high resolution scanner (HRRT) for measuring 5HT2AR availability in subjects greater than 60 years old. Methods: Six healthy subjects (age range = 65-78 years) completed two [18F]-setoperone PET scans on two separate occasions 5-16 weeks apart. Results: The average difference in the binding potential (BPND) as measured on the two occasions in the frontal and temporal cortical regions ranged between 2 and 12%, with the lowest intraclass correlation coefficient in anterior cingulate regions. Conclusion: We conclude that the test-retest variability of [18F]-setoperone PET in elderly subjects is comparable to that of [18F]-setoperone and other 5HT2AR radiotracers in younger subject samples.

Original languageEnglish (US)
Article number12
JournalBMC Medical Imaging
Volume9
DOIs
StatePublished - Jul 6 2009
Externally publishedYes

Fingerprint

Serotonin Receptors
Positron-Emission Tomography
Gyrus Cinguli
Receptor, Serotonin, 5-HT2A
Temporal Lobe
Geriatrics
Dementia
Healthy Volunteers
Tomography
setoperone
Pharmacology
Depression

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Test-retest variability of high resolution positron emission tomography (PET) imaging of cortical serotonin (5HT2A) receptors in older, healthy adults. / Chow, Tiffany W.; Mamo, David C.; Uchida, Hiroyuki; Graff-Guerrero, Ariel; Houle, Sylvain; Smith, Gwenn; Pollock, Bruce G.; Mulsant, Benoit H.

In: BMC Medical Imaging, Vol. 9, 12, 06.07.2009.

Research output: Contribution to journalArticle

Chow, Tiffany W. ; Mamo, David C. ; Uchida, Hiroyuki ; Graff-Guerrero, Ariel ; Houle, Sylvain ; Smith, Gwenn ; Pollock, Bruce G. ; Mulsant, Benoit H. / Test-retest variability of high resolution positron emission tomography (PET) imaging of cortical serotonin (5HT2A) receptors in older, healthy adults. In: BMC Medical Imaging. 2009 ; Vol. 9.
@article{30ef61e7cace4bd181bb2cd4bb851cea,
title = "Test-retest variability of high resolution positron emission tomography (PET) imaging of cortical serotonin (5HT2A) receptors in older, healthy adults",
abstract = "Background: Position emission tomography (PET) imaging using [18F]-setoperone to quantify cortical 5-HT2A receptors has the potential to inform pharmacological treatments for geriatric depression and dementia. Prior reports indicate a significant normal aging effect on serotonin 5HT2A receptor (5HT2AR) binding potential. The purpose of this study was to assess the test-retest variability of [18F]-setoperone PET with a high resolution scanner (HRRT) for measuring 5HT2AR availability in subjects greater than 60 years old. Methods: Six healthy subjects (age range = 65-78 years) completed two [18F]-setoperone PET scans on two separate occasions 5-16 weeks apart. Results: The average difference in the binding potential (BPND) as measured on the two occasions in the frontal and temporal cortical regions ranged between 2 and 12{\%}, with the lowest intraclass correlation coefficient in anterior cingulate regions. Conclusion: We conclude that the test-retest variability of [18F]-setoperone PET in elderly subjects is comparable to that of [18F]-setoperone and other 5HT2AR radiotracers in younger subject samples.",
author = "Chow, {Tiffany W.} and Mamo, {David C.} and Hiroyuki Uchida and Ariel Graff-Guerrero and Sylvain Houle and Gwenn Smith and Pollock, {Bruce G.} and Mulsant, {Benoit H.}",
year = "2009",
month = "7",
day = "6",
doi = "10.1186/1471-2342-9-12",
language = "English (US)",
volume = "9",
journal = "BMC Medical Imaging",
issn = "1471-2342",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Test-retest variability of high resolution positron emission tomography (PET) imaging of cortical serotonin (5HT2A) receptors in older, healthy adults

AU - Chow, Tiffany W.

AU - Mamo, David C.

AU - Uchida, Hiroyuki

AU - Graff-Guerrero, Ariel

AU - Houle, Sylvain

AU - Smith, Gwenn

AU - Pollock, Bruce G.

AU - Mulsant, Benoit H.

PY - 2009/7/6

Y1 - 2009/7/6

N2 - Background: Position emission tomography (PET) imaging using [18F]-setoperone to quantify cortical 5-HT2A receptors has the potential to inform pharmacological treatments for geriatric depression and dementia. Prior reports indicate a significant normal aging effect on serotonin 5HT2A receptor (5HT2AR) binding potential. The purpose of this study was to assess the test-retest variability of [18F]-setoperone PET with a high resolution scanner (HRRT) for measuring 5HT2AR availability in subjects greater than 60 years old. Methods: Six healthy subjects (age range = 65-78 years) completed two [18F]-setoperone PET scans on two separate occasions 5-16 weeks apart. Results: The average difference in the binding potential (BPND) as measured on the two occasions in the frontal and temporal cortical regions ranged between 2 and 12%, with the lowest intraclass correlation coefficient in anterior cingulate regions. Conclusion: We conclude that the test-retest variability of [18F]-setoperone PET in elderly subjects is comparable to that of [18F]-setoperone and other 5HT2AR radiotracers in younger subject samples.

AB - Background: Position emission tomography (PET) imaging using [18F]-setoperone to quantify cortical 5-HT2A receptors has the potential to inform pharmacological treatments for geriatric depression and dementia. Prior reports indicate a significant normal aging effect on serotonin 5HT2A receptor (5HT2AR) binding potential. The purpose of this study was to assess the test-retest variability of [18F]-setoperone PET with a high resolution scanner (HRRT) for measuring 5HT2AR availability in subjects greater than 60 years old. Methods: Six healthy subjects (age range = 65-78 years) completed two [18F]-setoperone PET scans on two separate occasions 5-16 weeks apart. Results: The average difference in the binding potential (BPND) as measured on the two occasions in the frontal and temporal cortical regions ranged between 2 and 12%, with the lowest intraclass correlation coefficient in anterior cingulate regions. Conclusion: We conclude that the test-retest variability of [18F]-setoperone PET in elderly subjects is comparable to that of [18F]-setoperone and other 5HT2AR radiotracers in younger subject samples.

UR - http://www.scopus.com/inward/record.url?scp=68949211240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68949211240&partnerID=8YFLogxK

U2 - 10.1186/1471-2342-9-12

DO - 10.1186/1471-2342-9-12

M3 - Article

C2 - 19580676

AN - SCOPUS:68949211240

VL - 9

JO - BMC Medical Imaging

JF - BMC Medical Imaging

SN - 1471-2342

M1 - 12

ER -